{"id":"https://genegraph.clinicalgenome.org/r/0d572995-852e-44f5-b235-a299382eb76av1.0","type":"EvidenceStrengthAssertion","dc:description":"SLC5A7: autosomal dominant CMT with vocal cord paresis, 09/28/2021\n\nSLC5A7 encodes a presynaptic solute-carrier protein responsible for choline uptake from the synaptic cleft. In 2012, WES revealed a truncating variant in the last exon of SLC5A7 co-segregating in a large family (LOD score: 6.32) with distal motor neuropathy and vocal cord paresis (PMID: 23141292). The authors showed that choline uptake is significantly impaired, demonstrating a dominant negative effect on the wildtype allele. The same variant was recurrently reported again (PMID: 26786006), and so were three more truncating mutations all affecting the last exon of the gene in different populations. All of these changes were predicted to not undergo nonsense-mediated RNA decay (PMIDs: 29582019, 29782645). In addition, the described phenotype was very consistent as well, sparing the sensory system, but commonly involving vocal cord paresis. In parallel, SLC5A7 was first described in the context of autosomal recessive congenital myasthenic syndrome in 2016 (MIM: 617143). Based on the autosomal dominant mode of inheritance with the dominant negative effect, the panel agreed on splitting the neuropathy from the myasthenia phenotype for the present curation. Experimental evidence showed that SLC5A7 is expressed in the neuromuscular junction (PMID: 15173594) and that loss of function results in an impaired choline uptake (PMID: 23132865). An animal model demonstrated that heterozygous KO mice are more vulnerable to choline uptake inhibitors than wildtype animals (PMID: 15173594). In summary, truncating mutations in the last exon of SLC5A7 are linked to a specific molecular mechanism and associated with a distinct phenotype. More reports will solidify the gene-disease relationship in the future. Based on the curated evidence, we classify the gene-disease relationship of SLC5A7 and autosomal dominant motor neuropathy with vocal cord paresis as moderate.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0d572995-852e-44f5-b235-a299382eb76a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2021-11-20T02:20:03.630Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10063","date":"2021-11-20T02:20:16.558Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7fe7ca3-3ffe-4b67-96e9-e28b34c9f967","type":"EvidenceLine","dc:description":"Recurrent variant, same population (=> score down), very specific phenotype and functional evidence (=> don't score down too much)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7fe7ca3-3ffe-4b67-96e9-e28b34c9f967_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Same variant as in Barwick et al., 2012, see disturbed superficial expression there","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/a7fe7ca3-3ffe-4b67-96e9-e28b34c9f967_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26786006","allele":{"id":"https://genegraph.clinicalgenome.org/r/d26a3e1a-070c-4d45-be33-59a8002617e9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021815.5(SLC5A7):c.1497del (p.Lys499fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/39495"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/d37781a1-1c38-4591-b1ad-92e1dab1a834","type":"EvidenceLine","dc:description":"no functional evidence  on variant level,  but very specific genetic machanism and phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d37781a1-1c38-4591-b1ad-92e1dab1a834_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29582019","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd47a61b-b633-48d5-97c5-bbb09a17618f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021815.5(SLC5A7):c.1530del (p.Lys510AsnfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2017997782"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/12a47518-33c3-4ef7-b5cd-08504517376c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12a47518-33c3-4ef7-b5cd-08504517376c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Disturbed surface expression shown by WB, reduced choline uptake","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/12a47518-33c3-4ef7-b5cd-08504517376c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23141292","allele":{"id":"https://genegraph.clinicalgenome.org/r/d26a3e1a-070c-4d45-be33-59a8002617e9"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/211ed233-df03-4bea-b7b4-c9e2768b6d38","type":"EvidenceLine","dc:description":"no functional evidence  on variant level,  but very specific genetic machanismand phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/211ed233-df03-4bea-b7b4-c9e2768b6d38_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29782645","allele":{"id":"https://genegraph.clinicalgenome.org/r/1d5be1a7-fa99-4521-8db7-33b525ff1516","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021815.5(SLC5A7):c.1526del (p.Pro509LeufsTer3)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2017997783"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ed72c79c-6e1f-41d6-b450-4a7e44bca3ae","type":"EvidenceLine","dc:description":"no functional evidence  on variant level,  but very specific genetic machanism and phenotype","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ed72c79c-6e1f-41d6-b450-4a7e44bca3ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29582019","allele":{"id":"https://genegraph.clinicalgenome.org/r/00f0e358-d9fb-4128-8023-19fbf90e11e2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_021815.5(SLC5A7):c.1563_1564del (p.His521GlnfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2017997781"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7a321a46-450e-4eed-b1ff-9a905ed93b46_proband_segregation","type":"FamilyCosegregation","dc:description":"2 segregations only","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29582019","rdfs:label":"Salter family 2","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/7a321a46-450e-4eed-b1ff-9a905ed93b46","type":"Family","rdfs:label":"Salter family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/cd1caaf1-8ded-42da-8436-fe718372dd96","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29582019","rdfs:label":"III.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":24,"allele":{"id":"https://genegraph.clinicalgenome.org/r/cd47a61b-b633-48d5-97c5-bbb09a17618f"},"detectionMethod":"Dideoxy sequencing for co-segregation analyses","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0007010","obo:HP_0002460","obo:HP_0001324","obo:HP_0001604","obo:HP_0001265","obo:HP_0009830","obo:HP_0003693","obo:HP_0001761","obo:HP_0000006","obo:HP_0003376","obo:HP_0001348","obo:HP_0100285","obo:HP_0007178"],"previousTesting":false,"secondTestingMethod":"Genotyping","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d37781a1-1c38-4591-b1ad-92e1dab1a834_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001265","obo:HP_0100285","obo:HP_0000006","obo:HP_0001761","obo:HP_0001604","obo:HP_0007010","obo:HP_0007178","obo:HP_0003376","obo:HP_0002460","obo:HP_0003693","obo:HP_0009830","obo:HP_0001324","obo:HP_0001348"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cd1caaf1-8ded-42da-8436-fe718372dd96"}},{"id":"https://genegraph.clinicalgenome.org/r/8d854614-fae9-4946-a5a8-a79a94a30a28_proband_segregation","type":"FamilyCosegregation","dc:description":"1 segregation only","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29582019","rdfs:label":"Salter family 1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/8d854614-fae9-4946-a5a8-a79a94a30a28","type":"Family","rdfs:label":"Salter family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/173eee95-7a24-4f3a-8174-bf8d21f144a7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29582019","rdfs:label":"IV.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":25,"allele":{"id":"https://genegraph.clinicalgenome.org/r/00f0e358-d9fb-4128-8023-19fbf90e11e2"},"detectionMethod":"Dideoxy sequencing for co-segregation analyses","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0003693","obo:HP_0001324","obo:HP_0000006","obo:HP_0002460","obo:HP_0007178","obo:HP_0001348","obo:HP_0003484"],"previousTesting":false,"secondTestingMethod":"Genotyping","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed72c79c-6e1f-41d6-b450-4a7e44bca3ae_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000006","obo:HP_0007178","obo:HP_0002460","obo:HP_0001324","obo:HP_0003484","obo:HP_0003693","obo:HP_0001348"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/173eee95-7a24-4f3a-8174-bf8d21f144a7"}},{"id":"https://genegraph.clinicalgenome.org/r/15cc7a12-da98-4a6c-ab72-bc5e79084b09_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23141292","rdfs:label":"Barwick family 1 ","estimatedLodScore":6.32,"family":{"id":"https://genegraph.clinicalgenome.org/r/15cc7a12-da98-4a6c-ab72-bc5e79084b09","type":"Family","rdfs:label":"Barwick family 1 ","member":{"id":"https://genegraph.clinicalgenome.org/r/8de56c16-91b1-4330-af6d-0c6faaaac6d2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23141292","rdfs:label":"IV.9","allele":{"id":"https://genegraph.clinicalgenome.org/r/d26a3e1a-070c-4d45-be33-59a8002617e9"},"detectionMethod":"Additional description in main text","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000006","obo:HP_0002460","obo:HP_0003693","obo:HP_0001604","obo:HP_0007178"],"previousTesting":true,"previousTestingDescription":"Genomic mapping, genome-wide linkage","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/12a47518-33c3-4ef7-b5cd-08504517376c_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":12,"phenotypePositiveAllelePositive":14,"phenotypes":["obo:HP_0000006","obo:HP_0001604","obo:HP_0007178","obo:HP_0003693","obo:HP_0002460"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/8de56c16-91b1-4330-af6d-0c6faaaac6d2"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/edcfea60-cec4-4629-9bf6-0fe489e9d32a_proband_segregation","type":"FamilyCosegregation","dc:description":"One segregation only","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29782645","rdfs:label":"Hamanaka family 1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/edcfea60-cec4-4629-9bf6-0fe489e9d32a","type":"Family","rdfs:label":"Hamanaka family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/b56e7d19-e324-49f0-877e-5500d8e42c47","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29782645","rdfs:label":"II.1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":52,"allele":{"id":"https://genegraph.clinicalgenome.org/r/1d5be1a7-fa99-4521-8db7-33b525ff1516"},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001605","obo:HP_0009830","obo:HP_0003693","obo:HP_0002015","obo:HP_0000006","obo:HP_0002460"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/211ed233-df03-4bea-b7b4-c9e2768b6d38_variant_evidence_item"}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002015","obo:HP_0000006","obo:HP_0002460","obo:HP_0003693","obo:HP_0001605","obo:HP_0009830"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b56e7d19-e324-49f0-877e-5500d8e42c47"}},{"id":"https://genegraph.clinicalgenome.org/r/dc684e89-fd7a-4ebe-a798-970238439495_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26786006","rdfs:label":"Ingram family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/dc684e89-fd7a-4ebe-a798-970238439495","type":"Family","rdfs:label":"Ingram family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/481e66b3-d65a-4021-9a85-9aa69f2a2396","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26786006","rdfs:label":"IV.1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":13,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d26a3e1a-070c-4d45-be33-59a8002617e9"},"detectionMethod":"No detailed information provided","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0001265","obo:HP_0003693","obo:HP_0000006","obo:HP_0002460","obo:HP_0007178","obo:HP_0001604","obo:HP_0001761"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a7fe7ca3-3ffe-4b67-96e9-e28b34c9f967_variant_evidence_item"}}},"phenotypeNegativeAlleleNegative":0,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000006","obo:HP_0007178","obo:HP_0001604","obo:HP_0002460","obo:HP_0001265","obo:HP_0001761","obo:HP_0003693"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/481e66b3-d65a-4021-9a85-9aa69f2a2396"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.25},{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fd40aa0b-f4cc-48dd-be68-5727722f8429","type":"EvidenceLine","dc:description":"Heterozygous LOF variant carriers ususally do not have a phenotype, which is mirrored in the mice. At specific stess reducing choline re-update, there is less than 50% of the channel function, imitating the dominant-negative situation in individuals with heterozygous LOF variants  in the last exon of the gene. The mouse model does not fully reflect the pathomechanism in humans, but it imitates it.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d78ff87f-ccaa-47cd-a627-e759ea1b869c","type":"Finding","dc:description":"Heterozygous SLC5A7 mice still express 50% of the protein, but under stress (choline-reuptake blockage) develop muscle weakness similar to the homozygous pups (congenital myasthenia model). In humans with heterozygous LOF variants in the last exon of SLC5A7 (no NMD), a dominant negative effect has been observed, demonstrating that less than 50% of the protein are efficiently working. This setting seems to be imitated by the animal model here.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15173594","rdfs:label":"SLC5A7 +/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c6e46608-98f5-4e4d-9bcf-22e42997af6e_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2d0a0d2-c14c-443c-aa5f-cc8031b141d9","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ef3124a-3a1d-4e6e-8896-a421848fb49d","type":"Finding","dc:description":"The experiments proof the idea of a dominant negative effect for certain heterozygous variant constellations, which is a very specific phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23132865","rdfs:label":"Cross-linking, choline uptake assay","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dde2a831-70fe-4537-8f83-183815495f2d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6b255345-1b07-4d30-9fa5-27dc2d59eeef","type":"Finding","dc:description":" CHT immunoreactivity is found in the axons and presynaptic terminals of motor neurons\nat CHT NMJs of the diaphragm","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15173594","rdfs:label":"Immunostaining for CHT in mouse neuromuscular junction","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Moderate","sequence":3679,"specifiedBy":"GeneValidityCriteria8","strengthScore":7.25,"subject":{"id":"https://genegraph.clinicalgenome.org/r/wNOIvW2-PRQ","type":"GeneValidityProposition","disease":"obo:MONDO_0008024","gene":"hgnc:14025","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_c6e46608-98f5-4e4d-9bcf-22e42997af6e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}